日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacokinetics, pharmacodynamics and safety of vutiglabridin after multiple oral administrations in healthy female and obese subjects

在健康女性和肥胖受试者中多次口服给药后,vutiglabridin 的药代动力学、药效学和安全性研究

Lee, Sooyoun; Kim, Hyun Chul; Yoon, Young Ran; Jang, In-Jin; Yoo, Sang-Ku; Yu, Kyung-Sang

Population Pharmacokinetic-Pharmacodynamic Analysis of Zolpidem in Healthy Volunteers: Covariate Contributions to Variability in CNS Responses

健康志愿者中唑吡坦的群体药代动力学-药效学分析:协变量对中枢神经系统反应变异性的影响

Kim, Hyun Chul; Sunwoo, Jung; Yoon, Seonghae; Jang, In-Jin; Chung, Jae-Yong

Population Pharmacokinetic and Pharmacodynamic Modeling of Enteric-Coated Aspirin Capsule and Tablet Formulations in Healthy Subjects.

健康受试者肠溶阿司匹林胶囊和片剂制剂的群体药代动力学和药效学模型

Koh JaeEun, Khwarg Juyoung, Yu Kyung-Sang, Lee SeungHwan, Jang In-Jin, Lee Soyoung

Saliva-based lacosamide monitoring paves the way toward personalized epilepsy pharmacotherapy

基于唾液的拉考沙胺监测为癫痫个体化药物治疗铺平了道路

Jang, Yoonhyuk; Ahn, Seon-Jae; Lee, Soyoung; Kim, Yongmoo; Lee, Han Sang; Lee, Yoon-Kyung; Shin, Yong Woo; Lee, Soon-Tae; Jung, Keun-Hwa; Park, Kyung-Il; Jung, Ki-Young; Cho, Joo-Youn; Lee, SeungHwan; Yu, Kyung-Sang; Chu, Kon; Jang, In-Jin; Lee, Sang Kun

Phase 1 studies of the safety, tolerability, pharmacokinetics, and pharmacodynamics of BI 690517 (vicadrostat), a novel aldosterone synthase inhibitor, in healthy male volunteers

在健康男性志愿者中开展的 BI 690517(维卡司他)——一种新型醛固酮合成酶抑制剂——的安全性、耐受性、药代动力学和药效学的 1 期研究

Schulze, Friedrich; Schaible, Jennifer; Goettel, Markus; Tanaka, Yuko; Hohl, Kathrin; Schultz, Armin; Jang, In-Jin

Population pharmacokinetic and pharmacodynamic model of evogliptin: Severe uremia increases the bioavailability of evogliptin

依格列汀的群体药代动力学和药效学模型:重度尿毒症增加依格列汀的生物利用度

Kim, Byungwook; Kim, Jung Eun; Lee, Soyoung; Oh, Jaeseong; Cho, Joo-Youn; Jang, In-Jin; Lee, SeungHwan; Chung, Jae-Yong; Yoon, Seonghae

Model-Informed Precision Dosing of Infliximab in Korean Inflammatory Bowel Disease Patients: External Validation of Population Pharmacokinetic Models

基于模型指导的英夫利昔单抗精准给药在韩国炎症性肠病患者中的应用:群体药代动力学模型的外部验证

Kim, Yoonjin; Baek, Seung Hwan; Jang, In-Jin; Chung, Jae-Yong

Comparing haploidentical transplantation with post-transplantation cyclophosphamide and umbilical cord blood transplantation using targeted busulfan in children and adolescents with hematologic malignancies

比较单倍体相合移植联合移植后环磷酰胺治疗以及采用靶向布苏凡的脐带血移植治疗儿童和青少年血液系统恶性肿瘤的疗效

Hong, Kyung Taek; Kim, Bo Kyung; An, Hong Yul; Choi, Jung Yoon; Song, Sang Hoon; Yu, Kyung-Sang; Jang, In-Jin; Kang, Hyoung Jin

Prospective phase II study of allogeneic hematopoietic stem cell transplantation with targeted busulfan, fludarabine, and etoposide conditioning in pediatric acute lymphoblastic leukemia

一项前瞻性II期研究,评估靶向布苏凡、氟达拉滨和依托泊苷预处理方案治疗儿童急性淋巴细胞白血病的异基因造血干细胞移植疗效。

Hong, Kyung Taek; Park, Hyun Jin; Kim, Bo Kyung; Choi, Jung Yoon; Song, Sang Hoon; Lee, SeungHwan; Yu, Kyung-Sang; Jang, In-Jin; Kang, Hyoung Jin

Pharmacokinetic Interactions Between the Fixed-Dose Combination of Ezetimibe/Rosuvastatin 10/20 Mg and the Fixed-Dose Combination of Telmisartan/Amlodipine 80/5 Mg in Healthy Subjects

健康受试者中依泽替米贝/瑞舒伐他汀10/20毫克固定剂量组合与替米沙坦/氨氯地平80/5毫克固定剂量组合的药代动力学相互作用

Ryu, Hyunwook; Kim, Hyun Chul; Jeon, Inseung; Jang, In-Jin; Cho, Joo-Youn; Kim, Kyung Tae; Oh, Jaeseong